Angiostatic peptide, endostatin, predicts severity in pediatric congenital heart disease–associated pulmonary hypertension

Daly, C. M., Griffiths, M., Simpson, C. E., Yang, J., Damico, R. L., Vaidya, R. D., Williams, M., Brandal, S., Jone, P., Polsen, C., Ivy, D. D., Austin, E. D., Nichols, W. C., Pauciulo, M. W., Lutz, K., Nies, M. K., Rosenzweig, E. B., Hirsch, R., Yung, D., & Everett, A. D. (2021). Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease–Associated Pulmonary Hypertension. Journal of the American Heart Association, 10(20). https://doi.org/10.1161/jaha.120.021409
Authors:
Caroline M. Daly
Megan Griffiths
Catherine E. Simpson
Jun Yang
Rachel L. Damico
R. Dhananjay Vaidya
Monica Williams
Stephanie Brandal
Pei-Ni Jone
Cassandra Polsen
D. Dunbar Ivy
Eric D. Austin
William C. Nichols
Michael W. Pauciulo
Katie Lutz
Melanie K. Nies
Erika B. Rosenzweig
Russel Hirsch
Delphine Yung
Allen D. Everett
Affiliated Authors:
Erika B. Rosenzweig
Author Keywords:
angiogenesis
biomarkers
children
proteomics
pulmonary vascular disease
Publication Type:
Article
Unique ID:
10.1161/JAHA.120.021409
PMID:
Publication Date:
Data Source:
Scopus

Record Created: